Ryvu Therapeutics (Poland) Alpha and Beta Analysis
| RVU Stock | 60.00 15.75 35.59% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Ryvu Therapeutics SA. It also helps investors analyze the systematic and unsystematic risks associated with investing in Ryvu Therapeutics over a specified time horizon. Remember, high Ryvu Therapeutics' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Ryvu Therapeutics' market risk premium analysis include:
Beta 0.0216 | Alpha 0.043 | Risk 5.31 | Sharpe Ratio 0.0753 | Expected Return 0.4 |
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Ryvu |
Ryvu Therapeutics Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Ryvu Therapeutics market risk premium is the additional return an investor will receive from holding Ryvu Therapeutics long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Ryvu Therapeutics. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Ryvu Therapeutics' performance over market.| α | 0.04 | β | 0.02 |
Ryvu Therapeutics Return and Market Media
The median price of Ryvu Therapeutics for the period between Tue, Aug 27, 2024 and Mon, Nov 25, 2024 is 58.7 with a coefficient of variation of 3.28. The daily time series for the period is distributed with a sample standard deviation of 1.92, arithmetic mean of 58.66, and mean deviation of 1.61. The Stock did not receive any noticable media coverage during the period. Price Growth (%) |
| Timeline |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Ryvu Therapeutics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Ryvu Therapeutics' short interest history, or implied volatility extrapolated from Ryvu Therapeutics options trading.
Build Portfolio with Ryvu Therapeutics
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Additional Tools for Ryvu Stock Analysis
When running Ryvu Therapeutics' price analysis, check to measure Ryvu Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ryvu Therapeutics is operating at the current time. Most of Ryvu Therapeutics' value examination focuses on studying past and present price action to predict the probability of Ryvu Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ryvu Therapeutics' price. Additionally, you may evaluate how the addition of Ryvu Therapeutics to your portfolios can decrease your overall portfolio volatility.